Published by Josh White on 21st February 2022
(Sharecast News) - Cancer therapy-focussed biotechnology company BiVictriX Therapeutics has filed four new patent applications in the UK, it announced on Monday, related to several novel cancer-specific antigen pairs - or 'fingerprints' - across a range of oncology indications.
URL: http://www.digitallook.com/dl/news/story/32477277/...